| # | % | |||||
|---|---|---|---|---|---|---|
| 101 | VERSARTIS INC | 3,436,585 | 52,305,000 | 0.46% | ||
| 102 | DBV TECHNOLOGIES S A | 1,862,019 | 55,451,000 | 0.49% | ||
| 103 | XOMA CORP DEL | 14,683,513 | 56,972,000 | 0.50% | ||
| 104 | ACORDA THERAPEUTICS INC | 59,583,000 | 60,049,000 | 0.53% | PRN | |
| 105 | CERUS CORP | 13,553,275 | 70,341,000 | 0.62% | ||
| 106 | Medivation Inc 04/01/2017 2.625% | 33,889,000 | 75,011,000 | 0.66% | PRN | |
| 107 | SPARK THERAPEUTICS INCORPORATED | 1,262,382 | 76,084,000 | 0.67% | ||
| 108 | HERON THERAPEUTICS INC COM | 2,807,784 | 87,491,000 | 0.77% | ||
| 109 | MIRATI THERAPEUTICS INC COM | 2,805,074 | 88,276,000 | 0.77% | ||
| 110 | BELLICUM PHARMACEUTICALS INCORPORATED | 4,190,594 | 89,134,000 | 0.78% | ||
| 111 | INVITAE CORP | 6,554,967 | 97,538,000 | 0.86% | ||
| 112 | GILEAD SCIENCES | 20,944,000 | 107,926,000 | 0.95% | PRN | |
| 113 | BIOMARIN PHARMACEUTICAL INC SR SB CV1.875 17 | 22,379,000 | 149,970,000 | 1.32% | PRN | |
| 114 | BIOCRYST PHARMACEUTICALS | 11,577,299 | 172,849,000 | 1.52% | ||
| 115 | DYAX CORP COM CVR | 7,926,630 | 210,056,000 | 1.84% | ||
| 116 | Anacor Pharmaceuticals Inc | 3,625,498 | 280,722,000 | 2.46% | ||
| 117 | GENOMIC HEALTH INC COM | 13,657,598 | 379,545,000 | 3.33% | ||
| 118 | INCYTE CORP SR NT CONV 4.750% 10/01/15 B/EDTD 03/30/10 0221 UBS FINANCIAL SERVICES INC. A/C MR06471 | 40,446,000 | 478,833,000 | 4.20% | PRN | |
| 119 | Incyte Corporation | 259,000,000 | 529,519,000 | 4.64% | PRN | |
| 120 | BIOMARIN PHARMACEUTICAL INC | 4,095,247 | 560,148,000 | 4.91% | ||
| 121 | Incyte Corporation | 274,500,000 | 567,758,000 | 4.98% | PRN | |
| 122 | ACADIA PHARMACEUTICALS INC COM | 20,481,442 | 857,763,000 | 7.52% | ||
| 123 | ABBVIE INC | 14,373,538 | 965,758,000 | 8.47% | ||
| 124 | ALEXION PHARMACEUTIC | 6,542,599 | 1,182,706,000 | 10.37% | ||
| 125 | SEATTLE GENETICS INC | 30,870,262 | 1,494,121,000 | 13.11% | ||
| 126 | INCYTE CORP | 14,865,559 | 1,549,140,000 | 13.59% |
Portfolio data is normalized using SEC Form 13F filings, including the Original 13F-HR (0001144204-15-049845, filed 2015.08.14).
From 2023-01-03 onward, the SEC requires values to be reported in nearest dollars. Earlier filings reported values in thousands; therefore, positions shown as $0 in older filings may represent actual values between $0–$999.
